Skip to content

Clinical trials

Phase 2 Urinary Bladder Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Urinary Bladder Neoplasms Phase: Phase 2 Clear all

381 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20008
20018
20024
200312
20048
20058
200611
200712
200818
200913
20109
201111
20128
20136
201415
201513
201610
201717
201829
201916
202021
202122
202215
202314
202412
202518
202621

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed168
Terminated66
Active, not recruiting43
Recruiting42
Unknown status34
Not yet recruiting15
Withdrawn13

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)31
Memorial Sloan Kettering Cancer Center19
M.D. Anderson Cancer Center14
SWOG Cancer Research Network9
University of Michigan Rogel Cancer Center7
European Organisation for Research and Treatment of Cancer - EORTC6
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano6
Dana-Farber Cancer Institute5
Eastern Cooperative Oncology Group5
Eli Lilly and Company5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Urinary Bladder Neoplasms381
Carcinoma, Transitional Cell68
Urethral Neoplasms49
Ureteral Neoplasms27
Non-Muscle Invasive Bladder Neoplasms24
Lung Neoplasms18
Carcinoma, Non-Small-Cell Lung17
Neoplasm Metastasis17
Ovarian Neoplasms17
Pancreatic Neoplasms16

Trials

Showing 26 to 50 of 381. Each trial links to its page on Pharma Observatory.

281 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.